Latest News in the pharma Industry

Research & Development

Alzheon presents positive results of ALZ-801 clinical studies

Alzheon presents positive results of ALZ-801 clinical studies

25 Jul 2016

Pharmacokinetic and safety data from Phase Ib studies with ALZ-801, an optimized prodrug of tramiprosate, presented at the Alzheimer's Association International Conference.

Read more 
Allergan receives Positive Opinion For Truberzi for treatment of IBS-D in adults

Allergan receives Positive Opinion For Truberzi for treatment of IBS-D in adults

25 Jul 2016

Significant step towards bringing the only licensed prescription medication for IBS-D to patients in 28 countries of the EU.

Read more 
AbbVie and BMS announce oncology clinical collaboration to evaluate the combination of Rova-T plus Opdivo and Opdivo + Yervoy regimen

AbbVie and BMS announce oncology clinical collaboration to evaluate the combination of Rova-T plus Opdivo and Opdivo + Yervoy regimen

25 Jul 2016

Collaboration will explore the safety and potential enhanced efficacy of combining checkpoint inhibitors with a cancer stem cell-targeting antibody drug conjugate in SCLC.

Read more 
N-of-One Secures $7 Million in Series B financing

N-of-One Secures $7 Million in Series B financing

24 Jul 2016

The financing will be used to expand the company's leading precision medicine decision support solutions in oncology.

Read more 
MRC Technology monetises royalties on cancer drug Keytruda to expand medical research activities

MRC Technology monetises royalties on cancer drug Keytruda to expand medical research activities

17 Jul 2016

The charity will now also be able to pursue exciting novel research and development collaborations with new partners.

Read more 
Lilly and Boehringer Ingelheim announce clinical trial collaboration in metastatic breast cancer

Lilly and Boehringer Ingelheim announce clinical trial collaboration in metastatic breast cancer

17 Jul 2016

Study to evaluate potential of novel combination therapy for hormone-receptor-positive, human epidermal growth factor receptor 2-negative (HR+, HER2-) metastatic breast cancer (mBC).

Read more 
Avacta and Glythera collaborate to develop novel, potentially highly potent, drug class

Avacta and Glythera collaborate to develop novel, potentially highly potent, drug class

14 Jul 2016

The collaboration will evaluate the use of Avacta’s Affimer technology in combination with Glythera’s PermaLink conjugation chemistry.

Read more 
EC grants marketing authorization for Gilead’s Epclusa for the treatment of all genotypes of chronic hepatitis C

EC grants marketing authorization for Gilead’s Epclusa for the treatment of all genotypes of chronic hepatitis C

10 Jul 2016

Epclusa is the first and only all-oral, single tablet regimen for all genotypes (1-6) of chronic hepatitis C virus infection and is Gilead’s third Sofosbuvir-based treatment.

Read more 
FDA approves Genentech’s Xolair for allergic asthma in children

FDA approves Genentech’s Xolair for allergic asthma in children

8 Jul 2016

Approval makes Xolair the only biologic for children ages six and up with uncontrolled allergic asthma.

Read more 
EC approves extended indication for Amgen's Kyprolis

EC approves extended indication for Amgen's Kyprolis

4 Jul 2016

Head-to-head Phase III trial demonstrated superiority of Kyprolis and dexamethasone over Velcade and dexamethasone in patients with relapsed multiple myeloma.

Read more 
Merck and Moderna collaborate to advance novel mRNA-based personalised cancer vaccines with Keytruda

Merck and Moderna collaborate to advance novel mRNA-based personalised cancer vaccines with Keytruda

4 Jul 2016

Collaboration combines Merck’s leadership in immuno-oncology with Moderna’s pioneering mRNA vaccine technology and rapid cycle time, small-batch GMP manufacturing capabilities.

Read more 
LEO Pharma enters biologics through strategic partnership with AstraZeneca

LEO Pharma enters biologics through strategic partnership with AstraZeneca

1 Jul 2016

The partnership covers potential new medicines for atopic dermatitis and psoriasis.

Read more